Literature DB >> 12368664

Brain glucose hypometabolism after perirhinal lesions in baboons: implications for Alzheimer disease and aging.

Isabelle Millien1, Xavier Blaizot, Cyrille Giffard, Florence Mézenge, Ricardo Insausti, Jean-Claude Baron, Chantal Chavoix.   

Abstract

The authors previously reported that excitotoxic lesions of both the perirhinal and entorhinal cortices in baboons induce remote neocortical and hippocampal hypometabolism reminiscent of that observed in Alzheimer disease (AD), suggesting that disconnection may play a role in AD. Because the cerebral metabolic rate of glucose (CMR ) was preferentially correlated with perirhinal damage, the area first affected by neurofibrillary tangles in both AD and normal aging, the present series of experiments aimed at assessing the specific metabolic effects of perirhinal lesions. Using PET, CMR was measured before surgery and sequentially over the ensuing 10 months. Compared with sham-operated baboons, perirhinal lesions induced significant-albeit late and transient-CMR decreases in several brain regions, which significantly correlated with histologic damage for some of these regions. Among them, the temporal and hippocampal regions are metabolically affected after extensive rhinal lesions, in early AD, and aging, while the prefrontal region is affected in aging only. Furthermore, in contrast to AD and rhinal lesions, the posterior cingulate cortex was spared. Both the progressive but significant metabolic effects and specific hypometabolic pattern after perirhinal lesions were confirmed by direct comparisons with previous data obtained after combined lesions of both rhinal areas. Thus, although perirhinal damage appears in itself insufficient to induce sustained CMR decreases, it may contribute to the hypometabolic profile of both AD and normal aging, most likely with a stronger contribution in the latter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368664     DOI: 10.1097/01.WCB.0000037997.34930.67

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  10 in total

Review 1.  Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.

Authors:  Adriane Dallanora Henriques; Andrea Lessa Benedet; Einstein Francisco Camargos; Pedro Rosa-Neto; Otávio Toledo Nóbrega
Journal:  Exp Gerontol       Date:  2018-01-04       Impact factor: 4.032

Review 2.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

Review 3.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

4.  Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.

Authors:  Nikolaos Scarmeas; Christian G Habeck; Eric Zarahn; Karen E Anderson; Aileen Park; John Hilton; Gregory H Pelton; Matthias H Tabert; Lawrence S Honig; James R Moeller; Davangere P Devanand; Yaakov Stern
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

5.  Effects of neonatal amygdala or hippocampus lesions on resting brain metabolism in the macaque monkey: a microPET imaging study.

Authors:  Christopher J Machado; Abraham Z Snyder; Simon R Cherry; Pierre Lavenex; David G Amaral
Journal:  Neuroimage       Date:  2007-09-26       Impact factor: 6.556

6.  Functional deactivations: change with age and dementia of the Alzheimer type.

Authors:  Cindy Lustig; Abraham Z Snyder; Mehul Bhakta; Katherine C O'Brien; Mark McAvoy; Marcus E Raichle; John C Morris; Randy L Buckner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-07       Impact factor: 11.205

7.  Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users.

Authors:  Oliver G Bosch; Michael Wagner; Frank Jessen; Kai-Uwe Kühn; Alexius Joe; Erich Seifritz; Wolfgang Maier; Hans-Jürgen Biersack; Boris B Quednow
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

Review 8.  Animal models of neurodegenerative disease: insights from in vivo imaging studies.

Authors:  Elissa M Strome; Doris J Doudet
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.484

9.  Prognostic value of posteromedial cortex deactivation in mild cognitive impairment.

Authors:  Jeffrey R Petrella; Steven E Prince; Lihong Wang; Caroline Hellegers; P Murali Doraiswamy
Journal:  PLoS One       Date:  2007-10-31       Impact factor: 3.240

Review 10.  In vivo Detection of Alzheimer's Disease.

Authors:  Antoine Leuzy; Kerstin Heurling; Nicholas J Ashton; Michael Schöll; Eduardo R Zimmer
Journal:  Yale J Biol Med       Date:  2018-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.